Advances in industrial biopharmaceutical batch process monitoring: Machine‐learning methods for small data problems

• Published in: Biotechnology and bioengineering 2018-08, Vol.115 (8), p.1915-1924
• Main Authors: Tulsyan, Aditya, Garvin, Christopher, Ündey, Cenk
• Format: Article
• Language: English
• Subjects: biopharmaceutical manufacturing; Biopharmaceuticals; Case studies; Exploitation; Learning algorithms; low‐N problem; Machine learning; Manufacturing; Monitoring; Production methods; Real variables; real‐time multivariate process monitoring; Signal processing
• ISSN: 0006-3592; 1097-0290
• DOI: 10.1002/bit.26605

Biopharmaceutical manufacturing comprises of multiple distinct processing steps that require effective and efficient monitoring of many variables simultaneously in real‐time. The state‐of‐the‐art real‐time multivariate statistical batch process monitoring (BPM) platforms have been in use in recent years to ensure comprehensive monitoring is in place as a complementary tool for continued process verification to detect weak signals. This article addresses a longstanding, industry‐wide problem in BPM, referred to as the “Low‐N” problem, wherein a product has a limited production history. The current best industrial practice to address the Low‐N problem is to switch from a multivariate to a univariate BPM, until sufficient product history is available to build and deploy a multivariate BPM platform. Every batch run without a robust multivariate BPM platform poses risk of not detecting potential weak signals developing in the process that might have an impact on process and product performance. In this article, we propose an approach to solve the Low‐N problem by generating an arbitrarily large number of in silico batches through a combination of hardware exploitation and machine‐learning methods. To the best of authors’ knowledge, this is the first article to provide a solution to the Low‐N problem in biopharmaceutical manufacturing using machine‐learning methods. Several industrial case studies from bulk drug substance manufacturing are presented to demonstrate the efficacy of the proposed approach for BPM under various Low‐N scenarios. A machine‐learning approach to generate in‐silico data (represented by yellow and red trajectories) using limited campaign data (represented by black trajectories) for biopharmaceutical batch process monitoring.